Back
Day Range
$20.34
$21.31
52-Week Range
$13.25
$30.00
Volume
377,569
50D / 200D Avg
$23.97
/
$22.08
Prev Close
$20.70
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.6 | 0.2 |
| P/B | 5.9 | 3.0 |
| ROE % | — | 3.6 |
| Net Margin % | -190.3 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$28.00
+36.1%
Low: $24.00
High: $30.00
Forward EPS
-$2.34
Est. Revenue
92.97M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$1.21
-$1.22 – -$1.19
|
268.97M | 2 |
| FY2028 |
-$1.77
-$2.08 – -$1.42
|
191.14M | 6 |
| FY2027 |
-$2.20
-$2.41 – -$1.94
|
132.90M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-17 | -$0.59 | -$0.61 | -3.4% |
| 2025-12-11 | -$0.59 | -$0.62 | -4.4% |
| 2025-09-11 | -$0.66 | -$0.46 | +30.3% |
| 2025-07-17 | N/A | -$1.05 | — |
| 2025-04-17 | N/A | -$0.43 | — |
| 2024-04-30 | N/A | -$0.45 | — |
| 2024-01-31 | N/A | -$0.44 | — |
| 2021-07-31 | N/A | -$0.27 | — |
Dividend History
Yield
0.00%
Payout Ratio
-0.01%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.22 — conservative balance sheet
Negative free cash flow of -101.20M
Capital intensive — 39.44% of revenue goes to capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)115.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-31.95%
Net Margin-190.28%
Op. Margin-177.85%
Safety
Debt / Equity
0.22
Current Ratio6.72
Interest Coverage-13.75
Valuation
P/E Ratio
-10.56
Forward P/EN/A
P/B Ratio5.85
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 115.05% | Revenue Growth (3Y) | 179.99% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 59.82M | Net Income (TTM) | -113.81M |
| ROE | N/A | ROA | -38.48% |
| Gross Margin | 40.47% | Operating Margin | -177.85% |
| Net Margin | -190.28% | Free Cash Flow (TTM) | -101.20M |
| ROIC | -31.95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 6.72 |
| Interest Coverage | -13.75 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | -0.01% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10.56 | Forward P/E | N/A |
| P/B Ratio | 5.85 | P/S Ratio | 20.08 |
| PEG Ratio | -0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 12.92 | Fwd Earnings Yield | N/A |
| FCF Yield | -8.42% | ||
| Market Cap | 1.20B | Enterprise Value | 1.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 59.82M | 27.81M | 7.63M | 0.0 | 0.0 |
| Net Income | -113.81M | -94.12M | -84.24M | -34.10M | -29.47M |
| EPS (Diluted) | -5.13 | -2.04 | -1.75 | -0.69 | -0.59 |
| Gross Profit | 24.21M | 362,000.0 | -10.65M | 0.0 | 0.0 |
| Operating Income | -106.38M | -85.06M | -80.42M | -32.71M | -29.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 295.74M | 45.95M | 38.66M | 30.52M | 7.87M |
| Total Liabilities | 90.34M | 255.33M | 156.23M | 28.76M | 4.02M |
| Shareholders' Equity | 205.41M | -209.38M | -117.58M | 1.77M | 3.86M |
| Total Debt | 44.31M | 45.17M | 39.13M | 22.85M | 452,000.0 |
| Cash & Equivalents | 237.60M | 8.25M | 14.81M | 24.34M | 5.76M |
| Current Assets | 255.33M | 14.91M | 18.42M | 26.20M | 6.17M |
| Current Liabilities | 37.98M | 32.97M | 36.74M | 6.61M | 4.02M |